Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat
- 21 November 1994
- journal article
- Published by Elsevier in Brain Research
- Vol. 664 (1-2) , 271-275
- https://doi.org/10.1016/0006-8993(94)91984-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacological effects of the non‐competitive NMDA antagonist CNS 1102 in normal volunteers.British Journal of Clinical Pharmacology, 1994
- Excitatory Amino Acids as a Final Common Pathway for Neurologic DisordersNew England Journal of Medicine, 1994
- Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion‐weighted MRINeurology, 1993
- Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicityJournal of Neuroscience, 1992
- Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemideEpilepsy Research, 1992
- Evaluation of a competitive NMDA antagonist (D‐CPPene) in feline focal cerebral ischemiaAnnals of Neurology, 1991
- Focal Cerebral Ischemia in the Cat: Pretreatment with a Competitive NMDA Receptor Antagonist, D-CPP-eneJournal of Cerebral Blood Flow & Metabolism, 1990
- Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related DrugsScience, 1989
- Focal Cerebral Ischaemia in the Cat: Treatment with the Glutamate Antagonist MK-801 after Induction of IschaemiaJournal of Cerebral Blood Flow & Metabolism, 1988
- Protective Effect of the Glutamate Antagonist, MK-801 in Focal Cerebral Ischemia in the CatJournal of Cerebral Blood Flow & Metabolism, 1988